Sign In
Buy AVTR
$9.07
+0.0800 (+0.89%)
At Close: Jun 03, 2026
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
07:17pm, Tuesday, 23'rd Jul 2024
NEW YORK , July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp. (NASD
Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for
11:05am, Friday, 19'th Jul 2024
Avantor (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now
01:21pm, Wednesday, 10'th Jul 2024
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
Avantor (AVTR) Launches Solutions for Gene Therapy Harvest
01:21pm, Tuesday, 02'nd Jul 2024
Avantor, Inc. AVTR recently released two innovative products aimed at revolutionizing the gene therapy harvest process. J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease are designed to enhance
Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease
08:05am, Monday, 01'st Jul 2024
Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at Scale RADNOR, Pa. , July 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provide
Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024
08:05am, Friday, 28'th Jun 2024
RADNOR, Pa. , June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology in
Avantor® Appoints Corey Walker as President of Laboratory Solutions
07:47am, Friday, 21'st Jun 2024
RADNOR, Pa. , June 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies
Avantor® Releases 2024 Science for Goodness Sustainability Report
08:05am, Tuesday, 18'th Jun 2024
Achieves 2025 Greenhouse Gas Emission reduction goals two years ahead of schedule RADNOR, Pa., June 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical p
Reasons Why You Should Retain Avantor (AVTR) Stock for Now
12:31pm, Thursday, 30'th May 2024
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
Avantor® to Participate in Goldman Sachs Global Healthcare Conference
08:05am, Wednesday, 29'th May 2024
RADNOR, Pa. , May 29, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies
Avantor® to Participate in Bernstein's 40th Annual Strategic Decisions Conference
08:05am, Tuesday, 21'st May 2024
RADNOR, Pa. , May 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies i
Avantor® to Participate in BofA Securities 2024 Health Care Conference
08:05am, Friday, 03'rd May 2024
RADNOR, Pa. , May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies in
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
01:36pm, Monday, 29'th Apr 2024
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.
Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript
10:57am, Friday, 26'th Apr 2024
Avantor Inc. (NYSE:AVTR ) Q1 2024 Earnings Conference Call April 26, 2024 8:00 AM ET Company Participants Christina Jones – Vice President-Investor Relations Michael Stubblefield – President and C
Avantor® Reports First Quarter 2024 Results
06:00am, Friday, 26'th Apr 2024
Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% Net income of $60 million; Adjusted EBITDA of $283 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 Operating cash flow of
